文献速递小儿神经外科与脑积水

血液β2转铁蛋白作为分流管功能状态标志物的初步结果

Initial Results of Using Blood Beta 2 Transferrin as a Marker of the Functional Status of a Shunt.
PubMed 文献 · World Neurosurg · 2019-04-30

本研究通过ELISA检测20例功能正常的脑室腹腔分流患者、10例年龄匹配健康志愿者和8例疑似分流故障患者的血清β2转铁蛋白水平。功能正常组分流管β2转铁蛋白为1.99±1.02 ng/mL,显著高于对照组的0.05±0.02 ng/mL(P<0.001)。疑似故障患者术前水平低(0.10±0.12 ng/mL),术后升至1.75±0.46 ng/mL(P=0.012)。

要点

  • 血清β2转铁蛋白在功能正常的分流管患者中显著高于健康对照。
  • 疑似分流故障患者术前β2转铁蛋白水平低,术后升高。
  • 血液β2转铁蛋白可能作为无创评估分流管功能的方法。

核心结论

  • 血液β2转铁蛋白可作为无创检测评估分流管功能状态。

研究设计与样本

  • 研究纳入20例功能正常的脑室腹腔分流患者、10例年龄匹配健康志愿者和8例疑似分流故障患者(6例脑室腹腔分流,2例腰腹腔分流),采用ELISA法检测血清β2转铁蛋白水平。

主要发现

  • 脑室腹腔分流组平均年龄36.5岁(范围24-50岁),对照组平均年龄39.5岁(范围32-48岁),两组年龄无统计学差异。
  • 脑室腹腔分流组β2转铁蛋白水平为1.99±1.02 ng/mL,对照组为0.05±0.02 ng/mL,差异有统计学意义(P<0.001)。
  • 疑似分流故障患者术前β2转铁蛋白水平低(0.10±0.12 ng/mL),术后升高至1.75±0.46 ng/mL,差异有统计学意义(P=0.012)。

临床怎么用

  • 对于疑似分流功能障碍的患者,可考虑检测血清β2转铁蛋白作为无创辅助评估手段。

局限性

  • 本研究为初步研究,样本量较小(功能正常组20例,疑似故障组8例),需进一步验证。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Ventriculoperitoneal shunt is the most common cerebrospinal fluid diversion procedure to treat hydrocephalus. With the change of physiologic cerebrospinal fluid absorption site from arachnoid granulations to the peritoneum, beta 2 transferrin enters the systemic circulation. Therefore, the detection of beta 2 transferrin in the blood can possibly be used as a noninvasive method to assess the functional status of the shunt. The objective of this study was to study the presence of beta 2 transferrin in patients with functional shunts and in shunts suspected of being malfunctional. METHODS: Blood samples were obtained from a group of 20 patients with functional ventriculoperitoneal shunts, from a control group of 10 age-matched healthy volunteers, and from 8 patients with suspected shunt malfunction (6 ventriculoperitoneal, 2 lumboperitoneal). Blood serum beta 2 transferrin levels were measured by enzyme-linked immunosorbent assay with specific anti-beta 2 transferrin antibodies. RESULTS: The mean age in the ventriculoperitoneal shunt group was 36.5 years (range, 24-50 years). The mean age in the control group was 39.5 years (range, 32-48). There was no statistical difference in age between the groups. Beta 2 transferrin levels were 1.99 ± 1.02 ng/mL in the ventriculoperitoneal shunt group and 0.05 ± 0.02 ng/mL in the control group; the statistical difference was strongly significant (P < 0.001). Patients presenting with suspected shunt malfunction had preoperative low beta 2 transferrin levels (0.10 ± 0.12). Postoperatively, their beta 2 transferrin levels increased to 1.75 ± 0.46 ng/mL, and the difference was statistically significant (P = 0.012). CONCLUSION: Blood beta 2 transferrin can be used as a noninvasive test to assess the functional status of a shunt.

来源:World Neurosurg,查看原文。版权归原作者所有。

引用

  1. Ozdol C, Kulaksizoglu S, Uyar R, et al. Initial Results of Using Blood Beta 2 Transferrin as a Marker of the Functional Status of a Shunt. World Neurosurg. 2019. PMID: 31048048. doi:10.1016/j.wneu.2019.04.185

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。